These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 10434927)
1. Metalloproteinases and tissue inhibitor of metalloproteinase 1 (TIMP-1) in endometrial flushings from pre- and post-menopausal women and from women with endometrial adenocarcinoma. Laird SM; Dalton CF; Okon MA; Bunning RA; Marshall R; Li TC J Reprod Fertil; 1999 Mar; 115(2):225-32. PubMed ID: 10434927 [TBL] [Abstract][Full Text] [Related]
2. Expression of metalloproteinases and their inhibitors in adenocarcinoma of the uterine cervix. Davidson B; Goldberg I; Liokumovich P; Kopolovic J; Gotlieb WH; Lerner-Geva L; Reder I; Ben-Baruch G; Reich R Int J Gynecol Pathol; 1998 Oct; 17(4):295-301. PubMed ID: 9785129 [TBL] [Abstract][Full Text] [Related]
3. [Activity of matrix metalloproteinases -2 and -9 (MMP-2 and MMP-9) and content of their tissue inhibitors in endometrial cancer--a preliminary study]. Bogusiewicz M; Stryjecka-Zimmer M; Rechberger T Ginekol Pol; 2007 May; 78(5):366-72. PubMed ID: 17867327 [TBL] [Abstract][Full Text] [Related]
4. Eutopic endometrium and peritoneal, ovarian and bowel endometriotic tissues express a different profile of matrix metalloproteinases-2, -3 and -11, and of tissue inhibitor metalloproteinases-1 and -2. Uzan C; Cortez A; Dufournet C; Fauvet R; Siffroi JP; Daraï E Virchows Arch; 2004 Dec; 445(6):603-9. PubMed ID: 15452706 [TBL] [Abstract][Full Text] [Related]
6. Significance of matrix metalloproteinase-7 [correction of matrix metalloproteinase-2], -11 and tissue inhibitor of metalloproteinase-1 expression in normal, hyperplastic and neoplastic endometrium. Obokata A; Watanabe J; Nishimura Y; Arai T; Kawaguchi M; Kuramoto H Anticancer Res; 2007; 27(1A):95-105. PubMed ID: 17352221 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage I and II endometrial cancer. Moser PL; Hefler L; Tempfer C; Neunteufel W; Kieback DG; Gitsch G Anticancer Res; 1999; 19(3B):2365-7. PubMed ID: 10472357 [TBL] [Abstract][Full Text] [Related]
8. A study of metalloproteinases in fifty joint fluid specimens. Gaudin P; Razakaboay M; Surla A; Berthier S; Fauconnier J; Morel F; Phelip X Rev Rhum Engl Ed; 1997 Jun; 64(6):375-81. PubMed ID: 9513609 [TBL] [Abstract][Full Text] [Related]
9. Is the measurement of placental protein-14 and CA-125 in plasma and uterine flushings useful in the evaluation of peri-menopausal and post-menopausal bleeding? Li TC; Okon MA; Dalton CF; Heatley M; Laird SM Hum Reprod; 1998 Oct; 13(1O):2895-901. PubMed ID: 9804252 [TBL] [Abstract][Full Text] [Related]
10. Metalloproteinase-2, -7 and -9 and tissue inhibitor of metalloproteinase-1 and -2 expression in normal, hyperplastic and neoplastic endometrium: a clinical-pathological correlation study. Graesslin O; Cortez A; Fauvet R; Lorenzato M; Birembaut P; Daraï E Ann Oncol; 2006 Apr; 17(4):637-45. PubMed ID: 16407419 [TBL] [Abstract][Full Text] [Related]
11. [Expression of matrix metalloproteinase-2, 9 and it's tissue inhibitor-1, 2 in endometrial carcinoma]. Guo W; Chen G; Zhu C; Wang H Zhonghua Fu Chan Ke Za Zhi; 2002 Oct; 37(10):604-7. PubMed ID: 12487935 [TBL] [Abstract][Full Text] [Related]
12. Role of tissue inhibitors of metalloproteinases (TIMPs) in colorectal carcinoma. Joo YE; Seo KS; Kim J; Kim HS; Rew JS; Park CS; Kim SJ J Korean Med Sci; 1999 Aug; 14(4):417-23. PubMed ID: 10485622 [TBL] [Abstract][Full Text] [Related]
13. Expression of metalloproteinases and their inhibitors in blood vessels in human endometrium. Freitas S; Meduri G; Le Nestour E; Bausero P; Perrot-Applanat M Biol Reprod; 1999 Oct; 61(4):1070-82. PubMed ID: 10491646 [TBL] [Abstract][Full Text] [Related]
15. Expression of matrix metalloproteinase-26 and tissue inhibitors of metalloproteinases TIMP-3 and -4 in benign endometrium and endometrial cancer. Tunuguntla R; Ripley D; Sang QX; Chegini N Gynecol Oncol; 2003 Jun; 89(3):453-9. PubMed ID: 12798711 [TBL] [Abstract][Full Text] [Related]
16. Focal expression and final activity of matrix metalloproteinases may explain irregular dysfunctional endometrial bleeding. Galant C; Berlière M; Dubois D; Verougstraete JC; Charles A; Lemoine P; Kokorine I; Eeckhout Y; Courtoy PJ; Marbaix E Am J Pathol; 2004 Jul; 165(1):83-94. PubMed ID: 15215164 [TBL] [Abstract][Full Text] [Related]
17. Epithelial and bacterial metalloproteinases and their inhibitors in H. pylori infection of human gastric cells. Göõz M; Göõz P; Smolka AJ Am J Physiol Gastrointest Liver Physiol; 2001 Sep; 281(3):G823-32. PubMed ID: 11518695 [TBL] [Abstract][Full Text] [Related]
18. Localization of MT1-MMP, TIMP-1, TIMP-2, and TIMP-3 messenger RNA in normal, hyperplastic, and neoplastic endometrium. Enhanced expression by endometrial adenocarcinomas is associated with low differentiation. Määttä M; Soini Y; Liakka A; Autio-Harmainen H Am J Clin Pathol; 2000 Sep; 114(3):402-11. PubMed ID: 10989641 [TBL] [Abstract][Full Text] [Related]
19. Mechanisms of irregular bleeding with hormone therapy: the role of matrix metalloproteinases and their tissue inhibitors. Hickey M; Crewe J; Mahoney LA; Doherty DA; Fraser IS; Salamonsen LA J Clin Endocrinol Metab; 2006 Aug; 91(8):3189-98. PubMed ID: 16684831 [TBL] [Abstract][Full Text] [Related]
20. 72-kDa and 92-kDa gelatinases in saliva of patients with human immunodeficiency virus infection. Mellanen L; Salo T; Ingman T; Konttinen YT; Lähdevirta J; Sorsa T Acta Odontol Scand; 1998 Jun; 56(3):135-42. PubMed ID: 9688221 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]